The effects of local review on informed consent documents from a multicenter clinical trials consortium

被引:68
|
作者
Burman, W
Breese, P
Weis, S
Bock, N
Bernardo, J
Vernon, A
机构
[1] Denver Publ Hlth, Denver, CO 80204 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
[3] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA
[4] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA
[5] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02215 USA
来源
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷 / 03期
关键词
institutional review board; consent form; human subjects protection; reading level; multicenter; clinical trials;
D O I
10.1016/S0197-2456(03)00003-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There is increasing controversy about the appropriate role of the local institutional review board in the review of multicenter clinical studies. We evaluated the effects of the local review process at 25 study sites on the consent forms from two studies of the Tuberculosis Trials Consortium, a multicenter trials group. Two independent reviewers classified all changes made in the centrally approved consent forms; a third reviewer evaluated those changes if the two initial reviewers disagreed. The median time to initial local approval was 104.5 days (range 31-346). There were no changes in the study protocols as a result of local review. Consent forms became longer and less readable after local review, with a mean increase in grade level of 0.9 (+/-0.9) reading grade levels (p < 0.001). A median of 46.5 changes (range 3-160) were made in the centrally approved forms. Most changes (85.2%) involved altering wording without affecting meaning. Errors were commonly introduced (11.2% of changes), and 33 of 50 (66%) locally approved consent forms contained at least one error in protocol presentation or a required consent form element. Local approval of two multicenter clinical trials was time-consuming and resulted in many changes in centrally approved consent forms. These changes frequently decreased readability and introduced errors. (C) 2003 by Elsevier Inc. All rights reserved.
引用
收藏
页码:245 / 255
页数:11
相关论文
共 50 条
  • [1] INFORMED CONSENT IN MULTICENTER TRIALS
    FITCH, LL
    LONG, JM
    MATTS, JP
    CONTROLLED CLINICAL TRIALS, 1988, 9 (03): : 273 - 273
  • [2] INFORMED CONSENT IN EUROPEAN MULTICENTER RANDOMIZED CLINICAL-TRIALS - ARE PATIENTS REALLY INFORMED
    WILLIAMS, CJ
    ZWITTER, M
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (07) : 907 - 910
  • [3] Informed consent in clinical trials
    Kovane, G. P.
    Nikoderm, V. C.
    Khondowe, O.
    SOUTH AFRICAN JOURNAL OF BIOETHICS AND LAW, 2022, 15 (02) : 48 - 53
  • [4] Informed consent in clinical trials
    Verheggen, FWSM
    vanWijmen, FCB
    HEALTH POLICY, 1996, 36 (02) : 131 - 153
  • [5] Obtaining informed consent in veterinary clinical trials mini review
    Frederick, Carol E.
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [6] INFORMED CONSENT IN CLINICAL-TRIALS
    BIRLEY, JLT
    LANCET, 1991, 337 (8753): : 1353 - 1353
  • [7] Informed consent in pediatric clinical trials
    Barfield, RC
    Church, C
    CURRENT OPINION IN PEDIATRICS, 2005, 17 (01) : 20 - 24
  • [8] READABILITY OF INFORMED CONSENT DOCUMENTS (1987-2007) FOR CLINICAL TRIALS: A LINGUISTIC ANALYSIS
    Sand, K.
    Eik-Nes, N. L.
    Loge, J. H.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2012, 7 (04) : 67 - 78
  • [9] CLINICAL-TRIALS AND INFORMED CONSENT
    WET, BSD
    SOUTH AFRICAN MEDICAL JOURNAL, 1977, 52 (03): : 101 - 101
  • [10] INFORMED CONSENT IN CLINICAL-TRIALS
    VONESSEN, CF
    LANCET, 1982, 1 (8282): : 1189 - 1189